Holen Sie sich die Stockscreener-App
13.84
2.47%
-0.35
Handel nachbörslich:
13.87
0.03
+0.22%
Tenax Therapeutics Inc Aktie (TENX) Neueste Nachrichten
Logos Global Management LP Acquires 615,000 Shares in Tenax Therapeutics Inc - GuruFocus
TENX PE Ratio & Valuation, Is TENX Overvalued - Intellectia AI
William Blair Maintains Outperform on Tenax Therapeutics (TENX) March 2026 - Meyka
Tenax Therapeutics Inc (TENX) Q4 Loss Widens, But Beats Estimates - AlphaStreet
Christopher Giordano Discloses Investment at Tenax Therapeutics with 6.79% Stake - TradingView
Tenax Therapeutics Inc (TENX) Reports Q4 Earnings - AlphaStreet
TENX: LEVEL trial enrollment completed early; global expansion and regulatory preparations advancing - TradingView
Tenax Therapeutics stock gains as trial enrollment complete By Investing.com - Investing.com Canada
Tenax Therapeutics Achieves Phase 3 LEVEL Study Patient Target and Reports 2025 Financial Results; Topline Data Expected Q3 2026 - Minichart
Tenax Therapeutics stock holds at Outperform at Leerink Partners By Investing.com - Investing.com Canada
Tenax Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Tenax Therapeutics Reports Q4 Loss - National Today
Tenax Therapeutics, Inc. 2025 Annual Report: Business Strategy, Risk Factors, Clinical Pipeline, and Regulatory Challenges - Minichart
Tenax Therapeutics 2025 Financials: Q4 Loss Beats Analyst EstimatesNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
TENAX Therapeutics 10-K: Net loss $52.6M, NOL $56.4M, cash runway into 2027 - TradingView
Tenax Therapeutics (NASDAQ: TENX) outlines Phase 3 PH-HFpEF strategy - Stock Titan
Tenax Therapeutics (TENX) Completes Patient Enrollment for Phase 3 LEVEL Study - GuruFocus
Tenax Therapeutics: Q4 Earnings Snapshot - Yahoo Finance
Tenax Therapeutics Q4 net loss widens on higher R&D expenses - TradingView
Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides ... - Bluefield Daily Telegraph
Tenax randomizes 230 in PH-HFpEF trial, cash lasting to 2027 - Stock Titan
Wall Street Recap: What insider trading reveals about Tenax Therapeutics Inc. stockMarket Rally & Low Risk Entry Point Tips - Naître et grandir
Tenax Therapeutics (NASDAQ:TENX) Shares Cross Above 200 Day Moving AverageHere's What Happened - MarketBeat
Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference - GlobeNewswire
How Tenax Therapeutics Inc. (TENX) Affects Rotational Strategy Timing - Stock Traders Daily
Tenax Therapeutics: Some Future Potential (NASDAQ:TENX) - Seeking Alpha
TENX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
RTW INVESTMENTS, LP Acquires Additional Shares in Tenax Therapeu - GuruFocus
(TENX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Market Wrap: What are Tenax Therapeutics Incs recent SEC filings showing - baoquankhu1.vn
RTW funds disclose 9.99% Tenax Therapeutics (TENX) ownership position - Stock Titan
Is Tenax Therapeutics Inc. stock a good pick for beginnersWeekly Market Report & Consistent Profit Alerts - mfd.ru
Tenax Therapeutics Shares Phase III Levosimendan Progress, H2 Data Timeline at Guggenheim Conference - MarketBeat
Is Tenax Therapeutics Inc. stock positioned for long term growthShort Setup & AI Enhanced Trading Alerts - mfd.ru
Is Tenax Therapeutics Inc. stock a safe haven asset2025 Sector Review & Low Drawdown Trading Techniques - mfd.ru
TENX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Will Tenax Therapeutics Inc. benefit from rising consumer demand2025 Price Action Summary & Real-Time Volume Analysis - mfd.ru
Tenax Therapeutics (NASDAQ:TENX) Stock Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
Will Tenax Therapeutics Inc. outperform tech stocksJuly 2025 Summary & Risk Adjusted Buy and Sell Alerts - mfd.ru
[SCHEDULE 13G] TENAX THERAPEUTICS, INC. Passive Investment Disclosure (>5%) - Stock Titan
Is Tenax Therapeutics Inc. stock a top performer YTDPortfolio Profit Report & Precise Entry and Exit Recommendations - mfd.ru
Responsive Playbooks and the TENX Inflection - Stock Traders Daily
Bear Alert: What hedge funds are buying Tenax Therapeutics IncWeekly Earnings Recap & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Tenax Therapeutics (NASDAQ:TENX) Shares Pass Above 200 Day Moving AverageShould You Sell? - MarketBeat
Tenax Therapeutics (NASDAQ:TENX) Shares Pass Above 200 Day Moving Average – Should You Sell? - Defense World
Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026 - Investing News Network
Risk Report: Is Harris Oakmark Etf Trust stock a hidden gemQuarterly Trade Summary & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Fundamentals Check: What is the next catalyst for Tenax Therapeutics IncPortfolio Return Summary & AI Forecasted Stock Moves - baoquankhu1.vn
Is Tenax Therapeutics Inc. still a buy after recent gains2025 Market Overview & Safe Capital Growth Tips - mfd.ru
Understanding the Setup: (TENX) and Scalable Risk - Stock Traders Daily
Tenax Therapeutics (NASDAQ:TENX) Shares Pass Above 200-Day Moving AverageHere's Why - MarketBeat
Aug Macro: Is Tenax Therapeutics Inc forming a double bottomWall Street Watch & Proven Capital Preservation Tips - baoquankhu1.vn
Aug Movers: Will CPSP face regulatory challengesTrade Risk Assessment & Risk Managed Investment Entry Signals - baoquankhu1.vn
Financial Survey: Biorestorative Therapies (NASDAQ:BRTX) vs. Tenax Therapeutics (NASDAQ:TENX) - Defense World
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):